Status: current, Defined. Date: 31-Dec 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4650701000168115 | epinephrine acid tartrate 7.2 mg / 4 mL + lidocaine hydrochloride 160 mg / 4 mL + tetracaine hydrochloride 20 mg / 4 mL gel, 4 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4650711000168117 | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | Is a | adrenaline (epinephrine) + tetracaine (amethocaine) + lidocaine | true | Inferred relationship | Some | ||
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | has manufactured dose form | gel | true | Inferred relationship | Some | ||
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | has Australian BoSS | adrenaline (epinephrine) acid tartrate | true | Inferred relationship | Some | 1875322072 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | has intended active ingredient | adrenaline (epinephrine) | true | Inferred relationship | Some | 1875322072 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | has unit of use | vial | true | Inferred relationship | Some | 363517424 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | has Australian BoSS | lidocaine hydrochloride | true | Inferred relationship | Some | 1525186935 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | has intended active ingredient | lidocaine | true | Inferred relationship | Some | 1525186935 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | has intended active ingredient | tetracaine (amethocaine) | true | Inferred relationship | Some | 863289576 | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | has Australian BoSS | tetracaine hydrochloride (AU substance) | true | Inferred relationship | Some | 863289576 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Laceraine Topical Wound Anaesthetic gel, 4 mL vial | Is a | True | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | Inferred relationship | Some | |
| adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, 5 x 4 mL vials | has MPUU | True | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, vial | Inferred relationship | Some | 1363466140 |
Reference Sets
Medicinal product unit of use reference set
FHIR